HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

K Hirata Selected Research

ganglioside M1b (GM1b)

8/2006Spectrum of neurological diseases associated with antibodies to minor gangliosides GM1b and GalNAc-GD1a.
5/2001Antecedent symptoms in Guillain-Barré syndrome: an important indicator for clinical and serological subgroups.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


K Hirata Research Topics

Disease

27Neoplasms (Cancer)
04/2010 - 01/2000
13Stomach Neoplasms (Stomach Cancer)
10/2007 - 01/2000
11Infection
06/2012 - 03/2000
10Neoplasm Metastasis (Metastasis)
12/2003 - 02/2000
9Miller Fisher Syndrome (Fisher Syndrome)
05/2008 - 05/2000
8Colorectal Neoplasms (Colorectal Cancer)
07/2007 - 01/2000
8Carcinoma (Carcinomatosis)
09/2005 - 02/2000
7Ophthalmoplegia (External Ophthalmoplegia)
08/2006 - 05/2000
6Asthma (Bronchial Asthma)
09/2009 - 12/2000
6Breast Neoplasms (Breast Cancer)
09/2008 - 01/2000
6Reperfusion Injury
01/2005 - 01/2000
5Ischemia
01/2005 - 01/2000
4Inflammation
11/2012 - 06/2002
4Encephalitis (Encephalitis, Rasmussen)
05/2008 - 03/2001
4Ataxia (Dyssynergia)
11/2005 - 05/2000
4Pancreatic Neoplasms (Pancreatic Cancer)
09/2004 - 01/2000
4Myocardial Infarction
08/2000 - 05/2000
3Body Weight (Weight, Body)
06/2012 - 01/2006
3Polyneuropathies (Polyneuropathy)
08/2005 - 06/2000
3Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
08/2005 - 06/2000
3Shock
01/2005 - 02/2000
3Chronic Obstructive Pulmonary Disease (COPD)
07/2003 - 10/2000
3Pain (Aches)
04/2000 - 02/2000
2Critical Illness (Critically Ill)
09/2012 - 06/2012
2REM Sleep Behavior Disorder
10/2011 - 06/2000
2Psoriasis (Pustulosis Palmaris et Plantaris)
06/2008 - 06/2005
2Wounds and Injuries (Trauma)
02/2006 - 01/2005
2Pulmonary Hypertension (Ayerza Syndrome)
07/2003 - 10/2000
2Charcot-Marie-Tooth Disease (Peroneal Muscular Atrophy)
01/2003 - 01/2001
2Lung Diseases (Lung Disease)
06/2002 - 05/2001
2Esophageal Neoplasms (Esophageal Cancer)
09/2001 - 02/2000
2Vascular Diseases (Vascular Disease)
08/2001 - 05/2000
2Diarrhea
05/2001 - 08/2000
2Colonic Neoplasms (Colon Cancer)
02/2001 - 01/2000
2Infarction
05/2000 - 05/2000
1Insulinoma
05/2014
1Rupture
03/2014
1Acute Liver Failure (Fulminant Hepatic Failure)
07/2013
1End Stage Liver Disease
07/2013
1Rhinitis
05/2008

Drug/Important Bio-Agent (IBA)

11Immunoglobulin G (IgG)IBA
05/2008 - 05/2000
7AntibodiesIBA
08/2006 - 03/2000
6Proteins (Proteins, Gene)IBA
04/2010 - 09/2001
5Fluorouracil (Carac)FDA LinkGeneric
11/2006 - 02/2000
5Messenger RNA (mRNA)IBA
12/2003 - 01/2000
5Immunoglobulin M (IgM)IBA
07/2001 - 06/2000
4beta CateninIBA
03/2008 - 03/2002
4Cisplatin (Platino)FDA LinkGeneric
10/2007 - 02/2000
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2003 - 11/2000
4Telomerase (Telomerase Reverse Transcriptase)IBA
09/2001 - 10/2000
3Carbon MonoxideIBA
09/2012 - 01/2003
3A-Form DNA (A-DNA)IBA
11/2005 - 06/2003
3Complementary DNA (cDNA)IBA
12/2003 - 07/2001
3AntigensIBA
07/2001 - 04/2000
3Nitric Oxide (Nitrogen Monoxide)FDA Link
06/2001 - 02/2000
2Glucose (Dextrose)FDA LinkGeneric
05/2014 - 03/2014
2LigandsIBA
11/2012 - 03/2008
2Fluconazole (Zonal)FDA LinkGeneric
09/2012 - 06/2012
2Cholecalciferol (Vitamin D3)FDA Link
06/2008 - 06/2005
2maxacalcitolIBA
06/2008 - 06/2005
2AutoantibodiesIBA
05/2008 - 08/2006
2ganglioside M1b (GM1b)IBA
08/2006 - 05/2001
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
08/2005 - 05/2001
2sulfoquinovosylacylglycerolIBA
01/2005 - 09/2004
2Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
07/2003 - 10/2000
2glycogen synthase kinase 3 betaIBA
06/2003 - 03/2002
2Serine (L-Serine)FDA Link
06/2003 - 03/2002
2RNA (Ribonucleic Acid)IBA
06/2003 - 03/2001
2Vascular Endothelial Growth Factor CIBA
06/2003 - 09/2001
2Threonine (L-Threonine)FDA Link
06/2003 - 03/2002
2Peroxynitrous Acid (Peroxynitrite)IBA
02/2003 - 06/2002
2Codon (Codons)IBA
03/2002 - 07/2000
2glucuronyl glucosamine glycan sulfate (Vessel)IBA
10/2001 - 05/2000
2Anti-Infective Agents (Microbicides)IBA
10/2001 - 08/2000
2Nitric Oxide Synthase (NO Synthase)IBA
06/2001 - 02/2000
2Myelin-Associated Glycoprotein (S-MAG)IBA
05/2001 - 06/2000
2sulfate-3-glucuronyl paraglobosideIBA
05/2001 - 06/2000
2irinotecan (Camptosar)FDA LinkGeneric
02/2001 - 06/2000
2Interleukin-12 (IL 12)IBA
11/2000 - 01/2000
2iodofiltic acidIBA
08/2000 - 05/2000
1BilirubinIBA
07/2013
1Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
07/2013
1Asialoglycoprotein ReceptorIBA
07/2013
1Serum AlbuminIBA
07/2013
1Heat-Shock Proteins (Heat-Shock Protein)IBA
11/2012
1CreatinineIBA
06/2012
1fosfluconazoleIBA
06/2012
1ethyl tert-butyl ether (ETBE)IBA
10/2011
13-Iodobenzylguanidine (Iobenguane)IBA
10/2011
1Angiopoietin-2IBA
09/2009
1tranilast (N 5')IBA
02/2009
1Small Interfering RNA (siRNA)IBA
09/2008
1pranlukastIBA
05/2008
1Leukotriene Receptors (Leukotriene Receptor)IBA
05/2008
1FRZB proteinIBA
03/2008

Therapy/Procedure

4Drug Therapy (Chemotherapy)
07/2000 - 02/2000
2Combination Drug Therapy (Combination Chemotherapy)
10/2007 - 02/2000
2Plasma Exchange
08/2005 - 05/2001
2Aftercare (After-Treatment)
06/2001 - 02/2000
2Intra-Arterial Infusions
07/2000 - 02/2000